Literature DB >> 10684604

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.

D Z Chen1, D V Patel, C J Hackbarth, W Wang, G Dreyer, D C Young, P S Margolis, C Wu, Z J Ni, J Trias, R J White, Z Yuan.   

Abstract

Peptide deformylase (PDF) is essential in prokaryotes and absent in mammalian cells, thus making it an attractive target for the discovery of novel antibiotics. We have identified actinonin, a naturally occurring antibacterial agent, as a potent PDF inhibitor. The dissociation constant for this compound was 0.3 x 10(-)(9) M against Ni-PDF from Escherichia coli; the PDF from Staphylococcus aureus gave a similar value. Microbiological evaluation revealed that actinonin is a bacteriostatic agent with activity against Gram-positive and fastidious Gram-negative microorganisms. The PDF gene, def, was placed under control of P(BAD) in E. coli tolC, permitting regulation of PDF expression levels in the cell by varying the external arabinose concentration. The susceptibility of this strain to actinonin increases with decreased levels of PDF expression, indicating that actinonin inhibits bacterial growth by targeting this enzyme. Actinonin provides an excellent starting point from which to derive a more potent PDF inhibitor that has a broader spectrum of antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684604     DOI: 10.1021/bi992245y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  76 in total

1.  Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms.

Authors:  C Giglione; A Serero; M Pierre; B Boisson; T Meinnel
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae.

Authors:  Pan F Chan; Karen M O'Dwyer; Leslie M Palmer; Jennifer D Ambrad; Karen A Ingraham; Chi So; Michael A Lonetto; Sanjoy Biswas; Martin Rosenberg; David J Holmes; Magdalena Zalacain
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

3.  Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials.

Authors:  H Howard Xu; John D Trawick; Robert J Haselbeck; R Allyn Forsyth; Robert T Yamamoto; Rich Archer; Joe Patterson; Molly Allen; Jamie M Froelich; Ian Taylor; Danny Nakaji; Randy Maile; G C Kedar; Marshall Pilcher; Vickie Brown-Driver; Melissa McCarthy; Amy Files; David Robbins; Paula King; Susan Sillaots; Cheryl Malone; Carlos S Zamudio; Terry Roemer; Liangsu Wang; Philip J Youngman; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Over-expression of peptide deformylase in chloroplasts confers actinonin resistance, but is not a suitable selective marker system for plastid transformation.

Authors:  Alicia Fernández-San Millán; Patricia Obregón; Jon Veramendi
Journal:  Transgenic Res       Date:  2010-10-09       Impact factor: 2.788

5.  Development and validation of a whole-cell inhibition assay for bacterial methionine aminopeptidase by surface-enhanced laser desorption ionization-time of flight mass spectrometry.

Authors:  Kenneth D Greis; Songtao Zhou; Richard Siehnel; Chuck Klanke; Alan Curnow; Jeremy Howard; Gerlinde Layh-Schmitt
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Phylogenomic and biochemical characterization of three Legionella pneumophila polypeptide deformylases.

Authors:  Jianzhong Huang; Glenn S Van Aller; Amy N Taylor; John J Kerrigan; Wu-Schyong Liu; Janice M Trulli; Zhihong Lai; David Holmes; Kelly M Aubart; James R Brown; Magdalena Zalacain
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

7.  Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes.

Authors:  Annika I Nilsson; Anna Zorzet; Anna Kanth; Sabina Dahlström; Otto G Berg; Dan I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

8.  High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

Authors:  Christophe Antczak; David Shum; Sindy Escobar; Bhramdeo Bassit; Earl Kim; Venkatraman E Seshan; Nian Wu; Guangli Yang; Ouathek Ouerfelli; Yue-Ming Li; David A Scheinberg; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2007-04-13

9.  Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.

Authors:  Sindy Escobar-Alvarez; Yehuda Goldgur; Guangli Yang; Ouathek Ouerfelli; Yueming Li; David A Scheinberg
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

10.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.